Učitavanje...

Design and Development of Therapies using Chimeric Antigen Receptor-Expressing T cells

Investigators developed chimeric antigen receptors (CARs) for expression on T cells more than 25 years ago. When the CAR is derived from an antibody, the resultant cell should combine the desirable targeting features of an antibody (e.g. lack of requirement for major histocompatibility complex recog...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dotti, Gianpietro, Gottschalk, Stephen, Savoldo, Barbara, Brenner, Malcolm K
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3874724/
https://ncbi.nlm.nih.gov/pubmed/24329793
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12131
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!